Followers | 14 |
Posts | 1041 |
Boards Moderated | 0 |
Alias Born | 10/20/2017 |
Wednesday, August 18, 2021 11:36:04 AM
""AND!!!""
As discussed in this presentation I have linked below, regarding a mouse study to curb the population of mice by rendering them infertile through injections as well as shedding, these Dr's and scientists in the presentation cited an uptick in chronic disease in the reproductive organs in females causing infertility, among other things such as an uptick increase of myocardial inflammation and disease after several months post vaccination in people.
That said, by my interpretation of the content In this presentation, I have a real scary thought that the governments around the world have all the information and data and are ignoring these facts because of the real agenda of curbing population growth!! This is my summation of the presentation below.
The vaccines are currently a major factor which will lead to a dramatic increase in chronic health disease in the future.
Anyway, my point is, Therapeutics "WILL NOT BE APPROVED ANYTIME SOON BECAUSE OUR GOVERNMENT WON'T ALLOW THE USE BECAUSE OF THEIR AGENDA!!!"
PLease listen to this presentation and spread it as fast as Covid. Our future and children's future depend on it.
Thank you.
The Awareness Foundation Covid 19 Roundtable - IN ONE PLACE
https://inoneplace.com/thewatch/item/a7VKK4WS0hA1874
Next stop HUMBL Street. Transfers to the S the R the N and the E train.Beware of the closing doors please.
Recent SRNE News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM
- Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the A • GlobeNewswire Inc. • 06/05/2023 01:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM